Friday, 16 October 2026European Markets

VAN DE VELDE, CHARGEURS, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Consumer Cyclical Sector.

Loading stream...

(vianews) - van de velde (van.br) is among this list of stock assets with the highest dividend rate and return on equity on the consumer cyclical sector.

financial asset price forward dividend yield return on equity
van de velde (van.br) €36.55 5.64% 24.06%
chargeurs (cri.pa) €15.39 4.97% 8.01%
ibersol,sgps (ibs.ls) €6.50 2.15% 35.54%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. van de velde (van.br)

5.64% forward dividend yield and 24.06% return on equity

van de velde nv, together with its subsidiaries, designs, develops, manufactures, and markets fashionable luxury lingerie and swimwear for women worldwide. it operates through two segments, wholesale and retail. the company offers its products under the primadonna, marie jo, andres sarda, and lingerie styling brands. it also operates retail websites under the name of rigby & peller, lincherie, andres sarda, and primadonna; and specialized boutiques and department stores. the company was founded in 1919 and is headquartered in schellebelle, belgium. van de velde nv is a subsidiary of van de velde holding nv.

earnings per share

as for profitability, van de velde has a trailing twelve months eps of €1.11.

pe ratio

van de velde has a trailing twelve months price to earnings ratio of 32.99. meaning, the purchaser of the share is investing €32.99 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.06%.

revenue growth

year-on-year quarterly revenue growth grew by 17.1%, now sitting on 211.96m for the twelve trailing months.

yearly top and bottom value

van de velde's stock is valued at €36.55 at 17:30 est, below its 52-week high of €39.95 and way higher than its 52-week low of €29.45.

more news about van de velde.

2. chargeurs (cri.pa)

4.97% forward dividend yield and 8.01% return on equity

chargeurs sa operates as a manufacturing and services company in france, europe, the americas, asia, and internationally. the company operates through luxury and technologies segments. it provides surface solutions, such as plastic and paper films, technical adhesives, and application machinery for manufacturers of surfaces or products comprising plastics, glass, stainless steel, aluminum, pre-coated metals, and polyvinyl chloride (pvc) profiles; interlinings for the luxury and fashion industries; accessories and leather goods; and supplies wool fibers. the company is also involved in the production and sale of coats, jackets, shirts, sports clothing, and other products; and production and distribution of personal protective equipment. in addition, it offers various solutions, including strategic consulting, master planning, design, development, publishing, curation, exhibitions, marketing, merchandising, digital content, communication, etc.; and the museum studio platform that includes a portfolio of services comprising project coordination and museum installations, as well as design and the creation of immersive and technological experiences, and production of audiovisual content and the publication of art books. the company was formerly known as chargetex 1 and changed its name to chargeurs sa in 1997. chargeurs sa was founded in 1872 and is headquartered in paris, france.

earnings per share

as for profitability, chargeurs has a trailing twelve months eps of €1.79.

pe ratio

chargeurs has a trailing twelve months price to earnings ratio of 8.6. meaning, the purchaser of the share is investing €8.6 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.01%.

more news about chargeurs.

3. ibersol,sgps (ibs.ls)

2.15% forward dividend yield and 35.54% return on equity

ibersol, s.g.p.s., s.a., through its subsidiaries, operates a network of restaurants in portugal, spain, and angola. the company operates restaurants under various brands, including pizza hut, pasta caffé, pans & company, ribs, fresco, santamaria, kentucky fried chicken, burger king, o' kilo, quiosques, pizza móvil, miit, taco bell, sol, silva carvalho catering e palace catering, travel, coffee counters, and other concessions contract. the company was founded in 1989 and is headquartered in porto, portugal. ibersol, s.g.p.s., s.a. is a subsidiary of atps - sgps, s.a.

earnings per share

as for profitability, ibersol,sgps has a trailing twelve months eps of €-0.92.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 35.54%.

earnings before interest, taxes, depreciation, and amortization

ibersol,sgps's ebitda is 102.67.

more news about ibersol,sgps.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com